Abivax S.A.
ABVX
73.20
-7.45
-9.24%
Abivax S.A.
US · ABVX
#1658 by market cap
Listed 2023
73.20
-7.45
-9.24%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
Recent news
-
Rating change
Truist Financial Maintains Abivax S.A.(ABVX.US) With Buy Rating, Maintains Target Price $135Market Newswire · 2026/6/22
-
Morgan Stanley Maintains Abivax S.A.(ABVX.US) With Buy Rating, Maintains Target Price $180Market Newswire · 2026/9/28
-
Rating change
Goldman Sachs Initiates Abivax S.A.(ABVX.US) With Buy Rating, Announces Target Price $155Market Newswire · 2026/9/10
-
Piper Sandler Maintains Abivax S.A.(ABVX.US) With Buy Rating, Maintains Target Price $175Market Newswire · 2026/10/21
-
Rating change
Analysts Have Conflicting Sentiments on These Healthcare Companies: Bicara Therapeutics Inc. (BCAX), Abivax SA Sponsored ADR (ABVX) and Arcutis Biotherapeutics (ARQT)TipRanks · 2026/5/26
-
Rating change
Piper Sandler Maintains Abivax S.A.(ABVX.US) With Buy Rating, Raises Target Price to $175Market Newswire · 2026/7/9
-
Barclays Maintains Abivax S.A.(ABVX.US) With Buy Rating, Maintains Target Price $148Market Newswire · 2026/10/20
-
Rating change
Analysts Offer Insights on Healthcare Companies: HeartFlow, Inc. (HTFL), Taysha Gene Therapies (TSHA) and Abivax SA Sponsored ADR (ABVX)TipRanks · 2026/6/30
-
Rating change
Jefferies Maintains Abivax S.A.(ABVX.US) With Buy Rating, Maintains Target Price $158Market Newswire · 2026/7/1
-
Rating change
Truist Financial Maintains Abivax S.A.(ABVX.US) With Buy Rating, Announces Target Price $155Market Newswire · 2026/7/2
-
Rating change
LifeSci Capital Maintains Abivax S.A.(ABVX.US) With Buy Rating, Maintains Target Price $170Market Newswire · 2026/6/17
-
Rating change
A Quick Look at Today's Ratings for Abivax S.A.(ABVX.US), With a Forecast Between $110 to $175Market Newswire · 2026/7/1
-
Rating change
A Quick Look at Today's Ratings for Abivax S.A.(ABVX.US), With a Forecast Between $135 to $175Market Newswire · 2026/6/16
-
Rating change
A Quick Look at Today's Ratings for Abivax S.A.(ABVX.US), With a Forecast Between $132 to $187Market Newswire · 2026/6/3
-
Rating change
Analysts Are Bullish on These Healthcare Stocks: Biohaven Ltd. (BHVN), Abivax SA Sponsored ADR (ABVX)TipRanks · 2026/5/30
-
BTIG Maintains Abivax S.A.(ABVX.US) With Buy Rating, Maintains Target Price $175Market Newswire · 2026/10/2
-
Guggenheim Maintains Abivax S.A.(ABVX.US) With Buy Rating, Maintains Target Price $175Market Newswire · 2026/10/20
-
Rating change
Wolfe Research Maintains Abivax S.A.(ABVX.US) With Buy Rating, Cuts Target Price to $136Market Newswire · 2026/6/4
-
Rating change
Morgan Stanley Maintains Abivax S.A.(ABVX.US) With Buy Rating, Raises Target Price to $180Market Newswire · 2026/7/24
-
Rating change
A Quick Look at Today's Ratings for Abivax S.A.(ABVX.US), With a Forecast Between $118 to $180Market Newswire · 2026/9/23
-
Abivax 1H Loss EUR165.9M ABVXDow Jones · 2026/9/22
-
Rating change
Barclays Maintains Abivax S.A.(ABVX.US) With Buy Rating, Maintains Target Price $148Market Newswire · 2026/6/4
-
Rating change
Guggenheim Maintains Abivax S.A.(ABVX.US) With Buy Rating, Maintains Target Price $175Market Newswire · 2026/7/2
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 20:02:37 · For reference only, not investment advice and not tailored to your situation.
Abivax S.A. discussion 0 comments